hgm-csf herpes simplex virus injection
Biologicalexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2012 (NCT01935453)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Oncolytic virusOTHER
Oncolytic virus other
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- hgm-csf herpes simplex virus injection
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01935453 | Phase 1 | May 1, 2012 | Beijing Bozhiyin T&S Co., Ltd., Capital Medical University, Fudan University, OrienGene Biotechnology Ltd. |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Beijing Bozhiyin T&S Co., Ltd. | For profit | 1 | 0 | 1 | 2012 |
| Capital Medical University | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Fudan University | Academic/Hospital | 1 | 0 | 1 | 2012 |
| OrienGene Biotechnology Ltd. | For profit | 1 | 1 | 1 | 2012 |
4 organizations
Page 1 / 1